AVALA — History
CCN 190267 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$64M
Latest Revenue (FY2022)
+12.9%
Revenue CAGR (3yr)
7.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $50M | $64M | $64M | +0.1% | +12.9% |
| Operating Expenses | $45M | $53M | $59M | +12.3% | +15.3% |
| Operating Margin | 11.3% | 17.5% | 7.4% | -57.6% | -19.1% |
| Net Income | $6M | $11M | $5M | -57.5% | -8.7% |
| Licensed Beds | 21 | 21 | 21 | +0.0% | +0.0% |
| Total Patient Days | 1,686 | 1,695 | 1,783 | +5.2% | +2.8% |
| Medicare Day % | 28% | 24% | 22% | -7.5% | -10.8% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +27.4% ($50M → $64M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.9%
This Hospital
+7.6%
State Avg
Latest Margin
7.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $71M | 5.5% |
| FY2024 (proj) | $78M | 3.5% |
| FY2025 (proj) | $85M | 1.5% |